TrialHaematologica2016

The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial.

Simon Rule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.